Rajkumar Chetty

1.4k total citations
11 papers, 1.1k citations indexed

About

Rajkumar Chetty is a scholar working on Epidemiology, Physiology and Pharmacology. According to data from OpenAlex, Rajkumar Chetty has authored 11 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 5 papers in Physiology and 4 papers in Pharmacology. Recurrent topics in Rajkumar Chetty's work include Adipokines, Inflammation, and Metabolic Diseases (6 papers), Adipose Tissue and Metabolism (4 papers) and Cardiovascular Disease and Adiposity (3 papers). Rajkumar Chetty is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (6 papers), Adipose Tissue and Metabolism (4 papers) and Cardiovascular Disease and Adiposity (3 papers). Rajkumar Chetty collaborates with scholars based in United Kingdom, Singapore and United States. Rajkumar Chetty's co-authors include Sudhesh Kumar, Philip G. McTernan, Anthony Barnett, C. L. McTernan, Ffolliott M. Fisher, Alison L. Harte, Stephen A. Smith, George Valsamakis, K Jenner and John F. S. Crocker and has published in prestigious journals such as Circulation, The Journal of Clinical Endocrinology & Metabolism and Journal of Allergy and Clinical Immunology.

In The Last Decade

Rajkumar Chetty

10 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rajkumar Chetty United Kingdom 9 707 576 327 260 247 11 1.1k
C. L. McTernan United Kingdom 9 538 0.8× 429 0.7× 246 0.8× 270 1.0× 169 0.7× 12 1.1k
Heiner Boeing Germany 10 793 1.1× 476 0.8× 238 0.7× 265 1.0× 269 1.1× 10 1.2k
Bastard Jp France 7 556 0.8× 489 0.8× 192 0.6× 176 0.7× 120 0.5× 11 1.1k
Jay J. Kuo United States 16 281 0.4× 400 0.7× 526 1.6× 240 0.9× 321 1.3× 18 1.3k
Lakshmi S. Tallam United States 15 249 0.4× 352 0.6× 399 1.2× 235 0.9× 264 1.1× 19 1.1k
Preeti Kishore United States 17 489 0.7× 526 0.9× 131 0.4× 316 1.2× 162 0.7× 36 1.2k
Tomoatsu Nakamura Japan 18 397 0.6× 418 0.7× 147 0.4× 301 1.2× 137 0.6× 41 1.3k
Aki Hiuge Japan 11 509 0.7× 500 0.9× 73 0.2× 311 1.2× 519 2.1× 11 1.2k
Petra Schling Germany 10 286 0.4× 405 0.7× 97 0.3× 445 1.7× 576 2.3× 13 1.2k
Miyao Matsubara Japan 11 489 0.7× 282 0.5× 176 0.5× 260 1.0× 212 0.9× 22 820

Countries citing papers authored by Rajkumar Chetty

Since Specialization
Citations

This map shows the geographic impact of Rajkumar Chetty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rajkumar Chetty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rajkumar Chetty more than expected).

Fields of papers citing papers by Rajkumar Chetty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rajkumar Chetty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rajkumar Chetty. The network helps show where Rajkumar Chetty may publish in the future.

Co-authorship network of co-authors of Rajkumar Chetty

This figure shows the co-authorship network connecting the top 25 collaborators of Rajkumar Chetty. A scholar is included among the top collaborators of Rajkumar Chetty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rajkumar Chetty. Rajkumar Chetty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Belvisi, Maria G., et al.. (2026). First-in-human study for londamocitinib (AZD4604), an inhaled selective JAK1 inhibitor. Journal of Allergy and Clinical Immunology.
2.
Mäenpää, Jukka, John Mo, Szilárd Nemes, et al.. (2024). AZD4604, An Inhaled, Selective JAK1 Inhibitor Reduces Fractional Exhaled Nitric Oxide in Patients with Mild Asthma; A Randomized, Single-Blind Phase 1 Study. Journal of Allergy and Clinical Immunology. 153(2). AB98–AB98. 4 indexed citations
3.
Valsamakis, Georgios, A. F. Jones, Rajkumar Chetty, et al.. (2008). MRI total sagittal abdominal diameter as a predictor of metabolic syndrome compared to visceral fat at L4–L5 level. Current Medical Research and Opinion. 24(7). 1853–1860. 8 indexed citations
4.
Al‐Daghri, Nasser M., Rajkumar Chetty, Philip G. McTernan, et al.. (2005). Serum resistin is associated with C-reactive protein and LDL- cholesterol in type 2 diabetes and coronary artery disease in a Saudi population. Cardiovascular Diabetology. 4(1). 10–10. 71 indexed citations
5.
Harte, Alison L., Philip G. McTernan, Rajkumar Chetty, et al.. (2005). Insulin-Mediated Upregulation of the Renin Angiotensin System in Human Subcutaneous Adipocytes Is Reduced by Rosiglitazone. Circulation. 111(15). 1954–1961. 113 indexed citations
6.
Valsamakis, George, A Anwar, Jeremy Tomlinson, et al.. (2004). 11β-Hydroxysteroid Dehydrogenase Type 1 Activity in Lean and Obese Males with Type 2 Diabetes Mellitus. The Journal of Clinical Endocrinology & Metabolism. 89(9). 4755–4761. 126 indexed citations
7.
Valsamakis, Georgios, Philip G. McTernan, Rajkumar Chetty, et al.. (2004). Modest weight loss and reduction in waist circumference after medical treatment are associated with favorable changes in serum adipocytokines. Metabolism. 53(4). 430–434. 156 indexed citations
8.
McTernan, Philip G., Ffolliott M. Fisher, George Valsamakis, et al.. (2003). Resistin and Type 2 Diabetes: Regulation of Resistin Expression by Insulin and Rosiglitazone and the Effects of Recombinant Resistin on Lipid and Glucose Metabolism in Human Differentiated Adipocytes. The Journal of Clinical Endocrinology & Metabolism. 88(12). 6098–6106. 237 indexed citations
9.
Chetty, Rajkumar, et al.. (2003). Severe hypokalaemia and weakness due to Nurofen® misuse. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 40(4). 422–423. 34 indexed citations
10.
Fisher, Ffolliott M., Philip G. McTernan, Georgios Valsamakis, et al.. (2002). Differences in Adiponectin Protein Expression: Effect of Fat Depots and Type 2 Diabetic Status. Hormone and Metabolic Research. 34(11/12). 650–654. 115 indexed citations
11.
McTernan, Philip G., C. L. McTernan, Rajkumar Chetty, et al.. (2002). Increased Resistin Gene and Protein Expression in Human Abdominal Adipose Tissue. The Journal of Clinical Endocrinology & Metabolism. 87(5). 2407–2410. 285 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026